Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riess

Showing results (1281-1290 of 1,489) with videos related to

Pageof 149
Sort By:
Human Molecular Genetics|May 23, 2003
Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's diseaseFrank P Marx, Carsten Holzmann, Karsten M Strauss, et al.
Journal of Medical Genetics|August 31, 2016
FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrumMiriam S Reuter, Angelika Riess, Ute Moog, et al.
Resuscitation|December 3, 2014
Bundled postconditioning therapies improve hemodynamics and neurologic recovery after 17 min of untreated cardiac arrestJason A Bartos, Timothy R Matsuura, Mohammad Sarraf, et al.
Cancer Research|December 13, 2018
Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion ProteinsDana S Neel, David V Allegakoen, Victor Olivas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2023
Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, et al.
Neurology|February 12, 2004
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson diseaseK Hedrich, A Djarmati, N Schäfer, et al.
Human Molecular Genetics|April 30, 2016
Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington diseaseRoy Tang Yi Teo, Xin Hong, Libo Yu-Taeger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2019
Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating <i>RET</i> Alterations and Oncogenic Signaling Pathway AberrationsThereasa A Rich, Karen L Reckamp, Young Kwang Chae, et al.
Human Molecular Genetics|September 26, 2013
Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic miceNicolas Casadei, Anne-Maria Pöhler, Cristina Tomás-Zapico, et al.
Journal for Immunotherapy of Cancer|June 1, 2022
Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancerMiguel Lopez de Rodas, Venkata Nagineni, Arvind Ravi, et al.
Pageof 149

Showing results (1281-1290 of 1,489) with videos related to

Sort By:
Pageof 149
Human Molecular Genetics|May 23, 2003
Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's diseaseFrank P Marx, Carsten Holzmann, Karsten M Strauss, et al.
Journal of Medical Genetics|August 31, 2016
FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrumMiriam S Reuter, Angelika Riess, Ute Moog, et al.
Resuscitation|December 3, 2014
Bundled postconditioning therapies improve hemodynamics and neurologic recovery after 17 min of untreated cardiac arrestJason A Bartos, Timothy R Matsuura, Mohammad Sarraf, et al.
Cancer Research|December 13, 2018
Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion ProteinsDana S Neel, David V Allegakoen, Victor Olivas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2023
Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, et al.
Neurology|February 12, 2004
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson diseaseK Hedrich, A Djarmati, N Schäfer, et al.
Human Molecular Genetics|April 30, 2016
Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington diseaseRoy Tang Yi Teo, Xin Hong, Libo Yu-Taeger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2019
Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating <i>RET</i> Alterations and Oncogenic Signaling Pathway AberrationsThereasa A Rich, Karen L Reckamp, Young Kwang Chae, et al.
Human Molecular Genetics|September 26, 2013
Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic miceNicolas Casadei, Anne-Maria Pöhler, Cristina Tomás-Zapico, et al.
Journal for Immunotherapy of Cancer|June 1, 2022
Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancerMiguel Lopez de Rodas, Venkata Nagineni, Arvind Ravi, et al.
Pageof 149